American Oncology Institute (AOI) in Mangalagiri proudly announces a groundbreaking advancement in the treatment of breast cancer. Recently, AOI successfully treated three high-risk patients with carcinoma breast
The US FDA has approved its treatment for patients over 12 with a rare genetic immunodeficiency disease, per X4 Pharmaceuticals. X4's mavorixafor, to be sold under the brand name Xolremdi, is the primary treatment to get U.S. endorsement...
Manipal Hospitals, a leading multispeciality hospital, added that it is gaining an 87% stake in Kolkata-based clinic chain Medica Synergie in a contract that industry sources said is expected to be worth an expected ₹1,400 crore...
Yokogawa Electric Corporation’s latest single-cell analysis solution, the Single Cellome™ System SS2000, has been featured in an article published in the high-profile journal Analytical Chemistry
PharmaLink Inc., a pharmaceutical reverse distribution firm, declared a strategic agreement with Review Results, which aims to upgrade drug well-being and review productivity in the pharmaceutical industry. The innovative agreement uses...
The state-of-the-art 10X GMP facility at IIT Bombay will expedite the translation of academic research into innovative medical products, bridging the gap between laboratory discoveries and real-world impact.The 10X GMP Facility at IIT Bombay is t...
Glenmark Pharma's share price on both the NSE and BSE soared to a 52-week high following the company's announcement of receiving approval from the US health regulator to market a generic version of an anti-inflammatory drug in the American market....
Amid controversy surrounding allegations of carcinogenic ethylene oxide, a type of pesticide, found in specific spice packets, MDH (Mahashian Di Hatti) has refuted these claims, stating they lack evidence. The renowned over-100-year-old brand emph...
Utility Therapeutics Ltd has received FDA approval for Pivya (pivmecillinam) tablets to treat female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible strains of Escherichia coli, Proteus mirabilis, and...
ImmunityBio, Inc, a biotechnology firm, declared that Anktiva (N-803, or nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) is now approved by the US Food and Drug Administration for the treatment of patients with BCG...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
